Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04916236
Title Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers (SHERPA)
Acronym SHERPA
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors The Netherlands Cancer Institute
Age Groups: adult | senior
Covered Countries NLD

Additional content available in CKB BOOST